Covid-19: WHO suspends UN supply of Covaxin over manufacturing deficiencies
The Bharat Biotech's COVID-19 vaccine, COVAXIN has been suspended by World Health Organization (WHO) from its Covax facility, announced the UN health body on Saturday attributing it to deficiencies in manufacturing practices.
"WHO confirms the suspension of supply of COVAXIN produced by Bharat (Biotech), through UN procurement agencies and recommending to countries that received the vaccine to take actions as appropriate," reads the WHO in a statement.
For more information, check out the full story on the link below:
No Impact On Covaxin Safety, Clarifies Bharat Biotech After WHO Suspension
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.